Cargando…

A Novel Risk-Scoring Model for Prediction of Premalignant and Malignant Lesions of Uterine Endometrium Among Symptomatic Premenopausal Women

PURPOSE: Uterine cancer is the second most prevalent cancer of the female genital tract, with 90% of it being of endometrial origin. The aim of this research was to create and validate a risk-scoring model using patients’ clinical variables in predicting premalignant and malignant lesions of the ute...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagepalli Srinivas, Sujatha, Kubakaddi, Shruthi Sangamesh, Polisetti, Samatha, Amber, Shiny, Guruvare, Shyamala, Vaman Pai, Muralidhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602894/
https://www.ncbi.nlm.nih.gov/pubmed/33149699
http://dx.doi.org/10.2147/IJWH.S268169
_version_ 1783603791236431872
author Bagepalli Srinivas, Sujatha
Kubakaddi, Shruthi Sangamesh
Polisetti, Samatha
Amber, Shiny
Guruvare, Shyamala
Vaman Pai, Muralidhar
author_facet Bagepalli Srinivas, Sujatha
Kubakaddi, Shruthi Sangamesh
Polisetti, Samatha
Amber, Shiny
Guruvare, Shyamala
Vaman Pai, Muralidhar
author_sort Bagepalli Srinivas, Sujatha
collection PubMed
description PURPOSE: Uterine cancer is the second most prevalent cancer of the female genital tract, with 90% of it being of endometrial origin. The aim of this research was to create and validate a risk-scoring model using patients’ clinical variables in predicting premalignant and malignant lesions of the uterine endometrium among premenopausal women with abnormal uterine bleeding (AUB). METHODS: This is a retrospective cohort study conducted at a tertiary hospital of Southern India for a period of 5 years from July 2014 to August 2019, including women aged ≤55 years who had AUB and underwent endometrial biopsy. The incidence of atypical endometrial hyperplasia (AEH) and endometrial cancer (EC) was determined, and clinical and demographic variables were compared among cases (AEH/EC) and controls (no AEH/EC) using simple logistic regression. A risk-scoring model was derived and validated with a split-sample internal validation method. RESULTS: A total of 472 premenopausal women presenting with AUB were included in the study. There were 20 women (4.2%) with AEH and eight (1.7%) with EC. We found a statistically significant positive correlation of an anovulatory pattern of bleeding (odds ratio [OR]=3.4; p=0.009), age ≥45 years (OR=1.12; p=0.01), body mass index (BMI) ≥30 kg/m(2) (OR=2.46; p=0.04) and diabetes mellitus (OR=3.00; p=0.02) with a higher risk of AEH/EC diagnosis upon histopathological examination of endometrial biopsy specimens of the study population. A risk-scoring model (PAD30) was created using these variables to predict premalignant and malignant endometrial lesions. The best cutoff score derived by the receiver operating characteristics (ROC) curve, of ≥5, had a sensitivity of 85.7% and specificity of 87.6% with an area under the curve (AUC) of 0.84 (95% CI 0.75–0.93; p=0.04). With a positive likelihood ratio of 6.91, our prediction model increases the post-test probability of AEH/EC to 30.6% from 6% of the pre-test probability. CONCLUSION: The proposed model demonstrated a moderate diagnostic accuracy in predicting premalignant and malignant lesions of the uterine endometrium among symptomatic premenopausal women.
format Online
Article
Text
id pubmed-7602894
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-76028942020-11-03 A Novel Risk-Scoring Model for Prediction of Premalignant and Malignant Lesions of Uterine Endometrium Among Symptomatic Premenopausal Women Bagepalli Srinivas, Sujatha Kubakaddi, Shruthi Sangamesh Polisetti, Samatha Amber, Shiny Guruvare, Shyamala Vaman Pai, Muralidhar Int J Womens Health Original Research PURPOSE: Uterine cancer is the second most prevalent cancer of the female genital tract, with 90% of it being of endometrial origin. The aim of this research was to create and validate a risk-scoring model using patients’ clinical variables in predicting premalignant and malignant lesions of the uterine endometrium among premenopausal women with abnormal uterine bleeding (AUB). METHODS: This is a retrospective cohort study conducted at a tertiary hospital of Southern India for a period of 5 years from July 2014 to August 2019, including women aged ≤55 years who had AUB and underwent endometrial biopsy. The incidence of atypical endometrial hyperplasia (AEH) and endometrial cancer (EC) was determined, and clinical and demographic variables were compared among cases (AEH/EC) and controls (no AEH/EC) using simple logistic regression. A risk-scoring model was derived and validated with a split-sample internal validation method. RESULTS: A total of 472 premenopausal women presenting with AUB were included in the study. There were 20 women (4.2%) with AEH and eight (1.7%) with EC. We found a statistically significant positive correlation of an anovulatory pattern of bleeding (odds ratio [OR]=3.4; p=0.009), age ≥45 years (OR=1.12; p=0.01), body mass index (BMI) ≥30 kg/m(2) (OR=2.46; p=0.04) and diabetes mellitus (OR=3.00; p=0.02) with a higher risk of AEH/EC diagnosis upon histopathological examination of endometrial biopsy specimens of the study population. A risk-scoring model (PAD30) was created using these variables to predict premalignant and malignant endometrial lesions. The best cutoff score derived by the receiver operating characteristics (ROC) curve, of ≥5, had a sensitivity of 85.7% and specificity of 87.6% with an area under the curve (AUC) of 0.84 (95% CI 0.75–0.93; p=0.04). With a positive likelihood ratio of 6.91, our prediction model increases the post-test probability of AEH/EC to 30.6% from 6% of the pre-test probability. CONCLUSION: The proposed model demonstrated a moderate diagnostic accuracy in predicting premalignant and malignant lesions of the uterine endometrium among symptomatic premenopausal women. Dove 2020-10-27 /pmc/articles/PMC7602894/ /pubmed/33149699 http://dx.doi.org/10.2147/IJWH.S268169 Text en © 2020 Bagepalli Srinivas et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Bagepalli Srinivas, Sujatha
Kubakaddi, Shruthi Sangamesh
Polisetti, Samatha
Amber, Shiny
Guruvare, Shyamala
Vaman Pai, Muralidhar
A Novel Risk-Scoring Model for Prediction of Premalignant and Malignant Lesions of Uterine Endometrium Among Symptomatic Premenopausal Women
title A Novel Risk-Scoring Model for Prediction of Premalignant and Malignant Lesions of Uterine Endometrium Among Symptomatic Premenopausal Women
title_full A Novel Risk-Scoring Model for Prediction of Premalignant and Malignant Lesions of Uterine Endometrium Among Symptomatic Premenopausal Women
title_fullStr A Novel Risk-Scoring Model for Prediction of Premalignant and Malignant Lesions of Uterine Endometrium Among Symptomatic Premenopausal Women
title_full_unstemmed A Novel Risk-Scoring Model for Prediction of Premalignant and Malignant Lesions of Uterine Endometrium Among Symptomatic Premenopausal Women
title_short A Novel Risk-Scoring Model for Prediction of Premalignant and Malignant Lesions of Uterine Endometrium Among Symptomatic Premenopausal Women
title_sort novel risk-scoring model for prediction of premalignant and malignant lesions of uterine endometrium among symptomatic premenopausal women
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602894/
https://www.ncbi.nlm.nih.gov/pubmed/33149699
http://dx.doi.org/10.2147/IJWH.S268169
work_keys_str_mv AT bagepallisrinivassujatha anovelriskscoringmodelforpredictionofpremalignantandmalignantlesionsofuterineendometriumamongsymptomaticpremenopausalwomen
AT kubakaddishruthisangamesh anovelriskscoringmodelforpredictionofpremalignantandmalignantlesionsofuterineendometriumamongsymptomaticpremenopausalwomen
AT polisettisamatha anovelriskscoringmodelforpredictionofpremalignantandmalignantlesionsofuterineendometriumamongsymptomaticpremenopausalwomen
AT ambershiny anovelriskscoringmodelforpredictionofpremalignantandmalignantlesionsofuterineendometriumamongsymptomaticpremenopausalwomen
AT guruvareshyamala anovelriskscoringmodelforpredictionofpremalignantandmalignantlesionsofuterineendometriumamongsymptomaticpremenopausalwomen
AT vamanpaimuralidhar anovelriskscoringmodelforpredictionofpremalignantandmalignantlesionsofuterineendometriumamongsymptomaticpremenopausalwomen
AT bagepallisrinivassujatha novelriskscoringmodelforpredictionofpremalignantandmalignantlesionsofuterineendometriumamongsymptomaticpremenopausalwomen
AT kubakaddishruthisangamesh novelriskscoringmodelforpredictionofpremalignantandmalignantlesionsofuterineendometriumamongsymptomaticpremenopausalwomen
AT polisettisamatha novelriskscoringmodelforpredictionofpremalignantandmalignantlesionsofuterineendometriumamongsymptomaticpremenopausalwomen
AT ambershiny novelriskscoringmodelforpredictionofpremalignantandmalignantlesionsofuterineendometriumamongsymptomaticpremenopausalwomen
AT guruvareshyamala novelriskscoringmodelforpredictionofpremalignantandmalignantlesionsofuterineendometriumamongsymptomaticpremenopausalwomen
AT vamanpaimuralidhar novelriskscoringmodelforpredictionofpremalignantandmalignantlesionsofuterineendometriumamongsymptomaticpremenopausalwomen